CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2017	May 01, 2016
Cash flows from operating activities:
Net income	$ 19,013	$ 8,312
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	20,378	21,512
Amortization of deferred financing costs	954	954
Share-based compensation expense	5,862	5,050
Gain on insurance recovery	(9,601)	0
Losses (gains) on assets, net	262	(3,516)
Provision for doubtful accounts	1,406	1,898
Provision for deferred income taxes	(113)	1,668
Excess tax (benefits) shortfalls from share-based compensation arrangements	(1,515)	390
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	12,232	25,299
Inventories	(8,617)	6,555
Income taxes receivable	982	(4,140)
Prepaid expenses and other	(1,875)	3,699
Accounts payable	(21,737)	(24,633)
Accrued expenses	(11,068)	(22,976)
Other, net	(189)	(59)
Net cash provided by operating activities	6,374	20,013
Cash flows from investing activities:
Acquisitions, net of cash acquired	0	(4,343)
Capital expenditures	(11,556)	(10,280)
Proceeds from sale of property, plant and equipment	2,533	4,663
Proceeds from insurance	420	0
Net cash used in investing activities	(8,603)	(9,960)
Cash flows from financing activities:
Refund (deposit) of restricted cash	240	(49)
Proceeds from stock options exercised	1,196	1,401
Excess tax benefits (shortfalls) from share-based compensation arrangements	1,515	(390)
Proceeds from Amended ABL facility	35,000	0
Payments on Amended ABL facility	(35,000)	0
Payments on term loan	(10,000)	(20,000)
Payments on note payable	(458)	(531)
Purchases of treasury stock	(5,922)	(12,381)
Net cash used in financing activities	(13,429)	(31,950)
Effect of exchange rate changes on cash and cash equivalents	(63)	151
Net decrease in cash and cash equivalents	(15,721)	(21,746)
Cash and cash equivalents at beginning of period	65,403	99,662
Cash and cash equivalents at end of period	$ 49,682	$ 77,916